David Sinclair: The GLP-1 Side Effect No One Talks About, What AI Found in His Lab, and Reversing Blindness | Q&A EP #251 - Moonshots with Peter Diamandis

This episode was filmed at the 2026 Abundance360 Summit. Learn more at https://www.abundance360.com/

This Q&A is about longevity, and especially how David Sinclair sees AI speeding up drug discovery, biological-age reversal, and the future of healthspan. It also covers GLP-1s, telomeres, genetics, muscle preservation, hormone replacement, indoor environment, and the role of mindset in aging well.

Get access to metatrends 10+ years before anyone else - https://qr.diamandis.com/metatrends

Peter H. Diamandis, MD, is the Founder of XPRIZE, Singularity University, ZeroG, and A360

David A. Sinclair, A.O., Ph.D., is a tenured Professor of Genetics at Harvard Medical School and a serial biotech entrepreneur. Peter H. Diamandis, MD, is the Founder of XPRIZE, Singularity University, ZeroG, and A360

–

My companies:

Apply to Dave's and my new fund:https://qr.diamandis.com/linkventureslanding

Go to Blitzy to book a free demo and start building today: https://qr.diamandis.com/blitzy

Your body is incredibly good at hiding disease. Schedule a call with Fountain Life to add healthy decades to your life, and to learn more about their Memberships: https://www.fountainlife.com/peter

Connect with Peter:

Connect with David

Listen to MOONSHOTS:

–